Прекращено
Фаза III
Россия
Docetaxel; Trastuzumab; Carboplatin; Bevacizumab; 5-Fluorouracil; Epirubicin; Cyclophosphamide · NSABP Foundation Inc
A Multicenter Phase III Randomized Trial of Adjuvant Therapy for Patients With HER2-Positive Node-Positive or High Risk Node-Negative Breast Cancer Comparing Chemotherapy Plus Trastuzumab With Chemotherapy Plus Trastuzumab Plus Bevacizumab